JP2008528534A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528534A5
JP2008528534A5 JP2007552587A JP2007552587A JP2008528534A5 JP 2008528534 A5 JP2008528534 A5 JP 2008528534A5 JP 2007552587 A JP2007552587 A JP 2007552587A JP 2007552587 A JP2007552587 A JP 2007552587A JP 2008528534 A5 JP2008528534 A5 JP 2008528534A5
Authority
JP
Japan
Prior art keywords
opioid
salt
dosage form
less
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007552587A
Other languages
English (en)
Japanese (ja)
Other versions
JP5704789B2 (ja
JP2008528534A (ja
Filing date
Publication date
Priority claimed from GBGB0501638.1A external-priority patent/GB0501638D0/en
Priority claimed from PCT/GB2005/050014 external-priority patent/WO2005079760A1/en
Application filed filed Critical
Priority claimed from PCT/EP2006/000727 external-priority patent/WO2006079550A2/en
Publication of JP2008528534A publication Critical patent/JP2008528534A/ja
Publication of JP2008528534A5 publication Critical patent/JP2008528534A5/ja
Application granted granted Critical
Publication of JP5704789B2 publication Critical patent/JP5704789B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007552587A 2005-01-28 2006-01-27 耐アルコール性剤形 Expired - Lifetime JP5704789B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB0501638.1A GB0501638D0 (en) 2005-01-28 2005-01-28 Particulates
GB0501638.1 2005-01-28
PCT/GB2005/050014 WO2005079760A1 (en) 2004-02-12 2005-02-11 Particulates
GBPCT/GB2005/050014 2005-02-11
US67050605P 2005-04-12 2005-04-12
US60/670,506 2005-04-12
US73033905P 2005-10-26 2005-10-26
US60/730,339 2005-10-26
PCT/EP2006/000727 WO2006079550A2 (en) 2005-01-28 2006-01-27 Alcohol resistant dosage forms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012284017A Division JP2013100306A (ja) 2005-01-28 2012-12-27 耐アルコール性剤形

Publications (3)

Publication Number Publication Date
JP2008528534A JP2008528534A (ja) 2008-07-31
JP2008528534A5 true JP2008528534A5 (enExample) 2008-10-23
JP5704789B2 JP5704789B2 (ja) 2015-04-22

Family

ID=34259727

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007552587A Expired - Lifetime JP5704789B2 (ja) 2005-01-28 2006-01-27 耐アルコール性剤形
JP2012284017A Pending JP2013100306A (ja) 2005-01-28 2012-12-27 耐アルコール性剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012284017A Pending JP2013100306A (ja) 2005-01-28 2012-12-27 耐アルコール性剤形

Country Status (11)

Country Link
EP (3) EP2289491A1 (enExample)
JP (2) JP5704789B2 (enExample)
CN (1) CN101132772B (enExample)
AP (1) AP2274A (enExample)
EA (1) EA015615B1 (enExample)
GB (1) GB0501638D0 (enExample)
IL (1) IL184858A (enExample)
MA (1) MA29368B1 (enExample)
NZ (2) NZ590772A (enExample)
TN (1) TNSN07293A1 (enExample)
ZA (1) ZA200705913B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
KR101528957B1 (ko) 2008-09-24 2015-06-17 에보니크 룀 게엠베하 에탄올의 영향에 대하여 내성을 갖는 ｐｈ-의존성 조절 방출 제약학적 오피오이드 조성물
US20110311631A1 (en) * 2009-03-18 2011-12-22 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
JP5619130B2 (ja) * 2009-03-18 2014-11-05 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングＥｖｏｎｉｋ ＲｏｅｈｍＧｍｂＨ 中性ビニルポリマーおよび賦形剤を含むコーティングを使用するエタノールの影響に対する耐性を有する制御放出性医薬組成物
GB0909680D0 (en) * 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
SG184523A1 (en) * 2010-05-10 2012-11-29 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
MX340188B (es) * 2010-05-10 2016-06-30 Euro-Celtique S A * Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
WO2011141490A1 (en) * 2010-05-10 2011-11-17 Euro-Celtique S.A. Combination of active loaded granules with additional actives
GB201020895D0 (en) * 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
HRP20170864T1 (hr) * 2011-06-01 2017-08-25 Fmc Corporation Čvrsti dozni oblici s kontroliranim oslobađanjem
WO2013057570A2 (en) * 2011-10-18 2013-04-25 Purdue Pharma L.P. Acrylic polymer formulations
LT2838512T (lt) * 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
CA2881144A1 (en) * 2012-11-09 2014-05-09 Purdue Pharma Pharmaceutical compositions comprising hydromorphone and naloxone
PE20151301A1 (es) * 2013-02-05 2015-09-16 Purdue Pharma Lp Formulaciones farmaceuticas resistentes a la manipulacion indebida
BR112020008756A2 (pt) 2017-11-01 2020-10-13 Edgemont Pharmaceuticals, LLC Trust composições farmacêuticas orais de lorazepam resistentes a álcool

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5656295A (en) 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
US5266331A (en) 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
US6306438B1 (en) * 1997-07-02 2001-10-23 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
US20030118641A1 (en) 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
SI2283842T1 (sl) * 2000-02-08 2015-07-31 Euro-Celtique S.A. Oralne formulacije opioidnih agonistov, varne pred zlorabo
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
IL160217A0 (en) * 2001-08-06 2004-07-25 Euro Celtique Sa Compositions and methods to prevent abuse of opioids
AU2002319774B2 (en) * 2001-08-06 2005-04-21 Euro-Celtique S.A. Compositions and methods to prevent abuse of opioids
LT2425821T (lt) * 2002-04-05 2017-07-25 Euro-Celtique S.A. Farmacinis preparatas, turintis oksikodono ir naloksono
WO2004004693A1 (en) 2002-07-05 2004-01-15 Collgegium Pharmaceutical Abuse-deterrent pharmaceutical compositions of opiods and other drugs
JP5189242B2 (ja) * 2002-09-23 2013-04-24 アルケルメス ファーマ アイルランド リミテッド 乱用抵抗性の医薬組成物
EP2218448B1 (en) * 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CN100500130C (zh) * 2003-01-23 2009-06-17 株式会社太平洋 缓释制剂及其制备方法
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
TWI350762B (en) * 2004-02-12 2011-10-21 Euro Celtique Sa Particulates

Similar Documents

Publication Publication Date Title
CA2913368C (en) Abuse deterrent immediate release formulation
JP2006524249A5 (enExample)
AU2008286914B2 (en) Abuse resistant drugs, method of use and method of making
HRP20100289T1 (hr) Proizvodi otporni na miješanje za opioidnu primjenu
US20160175454A1 (en) Tamper-Resistant Pharmaceutical Dosage Forms and Process for Making Same
JP4997109B2 (ja) 用量比例的な定常状態ｃａｖｅおよび定常状態ａｕｃ、ならびに、用量比例よりも小さい単回投与ｃｍａｘを有するオピオイド投薬形態物
US12208094B2 (en) Extended release, abuse deterrent dosage forms
JP2006524261A5 (enExample)
HRP20120641T1 (hr) Oralni farmaceutski oblici doziranja otporni na neovlašteno korištenje koji sadrže opioidni analgetik
CA2640339A1 (en) Tamper resistant opioid dosage forms
WO2013158810A1 (en) Immediate release pharmaceutical compositions with abuse deterrent properties
CA2938699A1 (en) Abuse-resistant drug formulations with built-in overdose protection
US20250017917A1 (en) Pharmaceutical dosage forms
WO2009015734A2 (en) Dosage form comprising immediate release naproxen and sustained release opioid analgesic
EP3079676A1 (en) Crush-resistant solid oral dosage form
WO2020159901A1 (en) Abrasion-resistant opioid formulations which resist abuse and include a sequestered opioid antagonist
KR20190028656A (ko) 내마모성 오피오이드 제형
US20200222329A1 (en) Abuse deterrent oral solid dosage form
TH86206A (th) ผลิตภัณฑ์ทางเภสัชกรรม
US20180185352A1 (en) Abuse deterrent pharmaceutical compositions